Press Release – New York, NY – June 30, 2025 – Sichenzia Ross Ference Carmel LLP announced that it represented INmune Bio (Nasdaq: INMB), a clinical-stage inflammation and immunology company, in its recently priced $19 million registered direct offering.
Alliance Global Partners served as the sole placement agent for the offering.
The SRFC team was led by partners Marc Ross, Thomas Rose and Thiago Spercel, with associates Christian Lichtenberger and Benjamin Sklar.
